Share Print

Lung Cancer

The statistics associated with lung cancer are sobering: The five-year survival rate is 15 percent, according to the American Cancer Society, and the disease accounts for more cancer-related deaths in the United States than any other, with about 160,000 projected for 2009.

Despite these numbers, physicians and researchers at the Siteman Cancer Center say the disease is treatable. In their clinics and labs, they are developing pioneering approaches that increase the odds for patients facing lung cancer.

  • Washington University physicians who treat lung cancer and other respiratory diseases at Barnes-Jewish Hospital and Siteman are ranked ninth in the nation by U.S. News & World Report.
  • They were the first in the area to use video-assisted thoracic surgery (VATS) to remove lung tumors using tiny incisions that help patients recover faster.
  • Siteman radiation oncologists offer a new high-dose therapy that can effectively treat patients with early stage lung cancers who are unable to undergo surgery.
  • More than 20 lung cancer clinical studies at Siteman provide patients with access to treatments not widely available at other centers.



Related Links

Patient Stories
Read about people who have successfully faced lung cancer.

Lung Cancer Podcasts
Listen to Siteman physicians discuss advances in treatment and the dangers of tobacco use.

Disease Information
Read about non-small cell lung cancer and small cell lung cancer, including information about treatment and staging.

Physician Team
Learn about Siteman doctors who treat lung cancer.

Know Your Risk 
Complete a lung cancer risk assessment.